Tanya Hagen-lee, CNP | |
1900 Grassland Dr, Mitchell, SD 57301-6335 | |
(605) 995-7000 | |
Not Available |
Full Name | Tanya Hagen-lee |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 3 Years |
Location | 1900 Grassland Dr, Mitchell, South Dakota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336711472 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | CP000818 (South Dakota) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Rural Health Care Inc | 3476447541 | 130 |
News Archive
The Trump administration announced that, for the first time, the average premium for a key plan sold on the federal health law's insurance marketplaces will fall slightly next year. Federal officials said that changes they have made helped facilitate the reduction, but others argue that it was because more plans are moving back into those federal exchanges and making money.
SignaBlok, Inc., a Massachusetts-based biopharmaceutical company, today announced the successful in vivo proof of concept data that demonstrate that the company's novel mechanism-based, first-in-class peptide inhibitor of TREM-1 effectively suppresses cancer progression in mouse models of lung cancer and dramatically improves survival in septic mice.
The University of Nottingham spin-out company, Critical Pharmaceuticals, has announced a -545,000 collaboration with the University to develop a nano-enabled intranasal formulation of teriparatide for the treatment of osteoporosis.
Guardian Home Care Holdings, Inc., a leading provider of home care and hospice services, announced it has entered into a business relationship with Cardiocom to provide advanced home telehealth technology to patients with chronic illnesses. Cardiocom is a developer, manufacturer and clinical service provider of award-winning telehealth solutions.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
› Verified 9 days ago
Entity Name | Avera Queen Of Peace |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205359031 PECOS PAC ID: 9335050806 Enrollment ID: O20031229000301 |
News Archive
The Trump administration announced that, for the first time, the average premium for a key plan sold on the federal health law's insurance marketplaces will fall slightly next year. Federal officials said that changes they have made helped facilitate the reduction, but others argue that it was because more plans are moving back into those federal exchanges and making money.
SignaBlok, Inc., a Massachusetts-based biopharmaceutical company, today announced the successful in vivo proof of concept data that demonstrate that the company's novel mechanism-based, first-in-class peptide inhibitor of TREM-1 effectively suppresses cancer progression in mouse models of lung cancer and dramatically improves survival in septic mice.
The University of Nottingham spin-out company, Critical Pharmaceuticals, has announced a -545,000 collaboration with the University to develop a nano-enabled intranasal formulation of teriparatide for the treatment of osteoporosis.
Guardian Home Care Holdings, Inc., a leading provider of home care and hospice services, announced it has entered into a business relationship with Cardiocom to provide advanced home telehealth technology to patients with chronic illnesses. Cardiocom is a developer, manufacturer and clinical service provider of award-winning telehealth solutions.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
› Verified 9 days ago
Entity Name | Rural Health Care Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720076441 PECOS PAC ID: 3476447541 Enrollment ID: O20040210000648 |
News Archive
The Trump administration announced that, for the first time, the average premium for a key plan sold on the federal health law's insurance marketplaces will fall slightly next year. Federal officials said that changes they have made helped facilitate the reduction, but others argue that it was because more plans are moving back into those federal exchanges and making money.
SignaBlok, Inc., a Massachusetts-based biopharmaceutical company, today announced the successful in vivo proof of concept data that demonstrate that the company's novel mechanism-based, first-in-class peptide inhibitor of TREM-1 effectively suppresses cancer progression in mouse models of lung cancer and dramatically improves survival in septic mice.
The University of Nottingham spin-out company, Critical Pharmaceuticals, has announced a -545,000 collaboration with the University to develop a nano-enabled intranasal formulation of teriparatide for the treatment of osteoporosis.
Guardian Home Care Holdings, Inc., a leading provider of home care and hospice services, announced it has entered into a business relationship with Cardiocom to provide advanced home telehealth technology to patients with chronic illnesses. Cardiocom is a developer, manufacturer and clinical service provider of award-winning telehealth solutions.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Tanya Hagen-lee, CNP 1900 Grassland Dr, Mitchell, SD 57301-6335 Ph: (605) 995-7000 | Tanya Hagen-lee, CNP 1900 Grassland Dr, Mitchell, SD 57301-6335 Ph: (605) 995-7000 |
News Archive
The Trump administration announced that, for the first time, the average premium for a key plan sold on the federal health law's insurance marketplaces will fall slightly next year. Federal officials said that changes they have made helped facilitate the reduction, but others argue that it was because more plans are moving back into those federal exchanges and making money.
SignaBlok, Inc., a Massachusetts-based biopharmaceutical company, today announced the successful in vivo proof of concept data that demonstrate that the company's novel mechanism-based, first-in-class peptide inhibitor of TREM-1 effectively suppresses cancer progression in mouse models of lung cancer and dramatically improves survival in septic mice.
The University of Nottingham spin-out company, Critical Pharmaceuticals, has announced a -545,000 collaboration with the University to develop a nano-enabled intranasal formulation of teriparatide for the treatment of osteoporosis.
Guardian Home Care Holdings, Inc., a leading provider of home care and hospice services, announced it has entered into a business relationship with Cardiocom to provide advanced home telehealth technology to patients with chronic illnesses. Cardiocom is a developer, manufacturer and clinical service provider of award-winning telehealth solutions.
In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis - a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions - researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.
› Verified 9 days ago
Theresa Miiller, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1900 Grassland Dr, Mitchell, SD 57301 Phone: 605-995-7000 | |
Heidi M Gehrke, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 525 N Foster St, Mitchell, SD 57301 Phone: 605-995-2000 | |
Kelly Jo Mcdermott, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 525 N Foster St, Mitchell, SD 57301 Phone: 605-995-5701 Fax: 605-995-5700 | |
Ms. Penny Petersen, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 525 N Foster St, Mitchell, SD 57301 Phone: 605-995-2000 | |
Kristin J Bietz, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 120 W 6th Ave, Mitchell, SD 57301 Phone: 605-292-6262 | |
Angela Mae Broughton, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1900 Grassland Dr, Mitchell, SD 57301 Phone: 605-995-7000 | |
Kim Denise Kee, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1200 E 6th Ave, Mitchell, SD 57301 Phone: 605-996-3380 Fax: 605-996-3385 |